Six years experience using inhalatory interleukin-2 in pulmonary metastatic renal cell carcinoma

被引：0
|
作者：
Huland, E [1 ]
Heinzer, H [1 ]
Huland, H [1 ]
机构：
[1] UNIV HAMBURG,CLIN EPPENDORF,DEPT UROL,HAMBURG,GERMANY
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：373 / 373
页数：1
相关论文
共 50 条
  • [31] Interleukin-2 continuous infusion and angiogenesis surrogate markers in metastatic renal cell carcinoma
    Simonelli, C.
    Talamini, R.
    Bearz, A.
    Berretta, M.
    Spazzapan, S.
    Monini, P.
    Sgadari, C.
    Sartor, I.
    Ensoli, B.
    Tirelli, U.
    ANNALS OF ONCOLOGY, 2006, 17 (08) : 1335 - U3
  • [32] High-dose interleukin-2 in metastatic disease: Renal cell carcinoma and melanoma
    Dutcher, J
    ONCOLOGY-NEW YORK, 2002, 16 (11): : 3 - 3
  • [33] MYOSITIS ASSOCIATED WITH INTERLEUKIN-2 THERAPY IN A PATIENT WITH METASTATIC RENAL-CELL CARCINOMA
    ESTEVALORENZO, F
    JANIK, JE
    FENTON, RG
    EMSLIESMITH, A
    ENGEL, AG
    LONGO, DL
    CANCER, 1995, 76 (07) : 1219 - 1223
  • [34] THE HEMATOLOGIC TOXICITY OF INTERLEUKIN-2 IN PATIENTS WITH METASTATIC MELANOMA AND RENAL-CELL CARCINOMA
    MACFARLANE, MP
    YANG, JC
    GULERIA, AS
    WHITE, RL
    SEIPP, CA
    EINHORN, JH
    WHITE, DE
    ROSENBERG, SA
    CANCER, 1995, 75 (04) : 1030 - 1037
  • [35] Prognostic markers for survival in patients with metastatic renal cell carcinoma treated with interleukin-2
    Van Bezooijen R.L.
    Goey H.
    Stoter G.
    Hermans J.
    Fleuren G.J.
    Cancer Immunology, Immunotherapy, 1997, 43 (5) : 293 - 298
  • [36] REVERSIBLE NEUROTOXICITY DURING INTERLEUKIN-2 THERAPY FOR METASTATIC RENAL-CELL CARCINOMA
    VANLAAR, JM
    VANBUCHEM, MA
    WEYL, N
    CLETON, FJ
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (11) : 1895 - 1897
  • [37] LOW-DOSE INTERLEUKIN-2 IN THE TREATMENT OF METASTATIC RENAL-CELL CARCINOMA
    STADLER, WM
    VOGELZANG, NJ
    SEMINARS IN ONCOLOGY, 1995, 22 (01) : 67 - 73
  • [38] RECOMBINANT INTERLEUKIN-2 FOR METASTATIC RENAL-CELL CARCINOMA IN HEMODIALYSIS-PATIENTS
    BUTER, J
    JANSSEN, RAJ
    MULDER, NH
    DEJONG, PE
    DELEIJ, L
    SLEIJFER, DT
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (10) : 1770 - 1771
  • [39] Symptomatic neurological epidural metastasis with interleukin-2 therapy in metastatic renal cell carcinoma
    Trufflandier, N
    Gille, O
    Palussière, J
    Prié, L
    Pointillart, V
    Ravaud, A
    TUMORI, 2002, 88 (04) : 338 - 340
  • [40] Prognostic markers for survival in patients with metastatic renal cell carcinoma treated with interleukin-2
    vanBezooijen, RL
    Goey, H
    Stoter, G
    Hermans, J
    Fleuren, GJ
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1996, 43 (05) : 293 - 298
12345